Analyst Consensus ?
ConsensusBuy19 ratings
Bullish1157.9%
Neutral842.1%
Bearish00.0%
FN2 Earnings Intelligence
GE HealthCare Technologies Inc. analyst ratings
GE HealthCare Technologies Inc. (GEHC) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$75.82Current
$65Low
$86.23Average
$110High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BTIG | Buy | Buy | Maintain | Oct 12, 2026 |
| Needham | Buy | Buy | Maintain | Oct 5, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 5, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 31, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 30, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Apr 30, 2026 |
| Goldman Sachs | Neutral | Buy | Downgrade | Apr 30, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Apr 30, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Apr 17, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Apr 13, 2026 |
| Stifel | Buy | Buy | Maintain | Feb 5, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Feb 5, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jan 5, 2026 |
| Jefferies | Buy | Buy | Maintain | Dec 11, 2025 |
| Argus Research | Buy | Buy | Maintain | Apr 1, 2024 |
| Oppenheimer | Outperform | Outperform | Maintain | May 16, 2023 |
| Redburn Partners | Buy | Buy | Maintain | Jan 19, 2023 |
| Edward Jones | Hold | Hold | Maintain | Jan 4, 2023 |
Named analyst price targets
Upside is calculated against the persisted current price $75.82. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $85 | $64.77 | +12.1% | Oct 6, 2026 |
| Needham | Analyst unavailable | $93 | $64.81 | +22.7% | Sep 22, 2026 |
| Evercore ISI | Analyst unavailable | $84 | $69.06 | +10.8% | Jul 30, 2026 |
| BTIG | Analyst unavailable | $79 | $71.54 | +4.2% | Jul 29, 2026 |
| UBS | Analyst unavailable | $67 | $64.23 | -11.6% | Jul 16, 2026 |
| BTIG | Ryan Zimmerman | $75 | $64.7 | -1.1% | Jul 13, 2026 |
| BMO Capital | Analyst unavailable | $70 | $64.68 | -7.7% | Jul 8, 2026 |
| RBC Capital | Analyst unavailable | $80 | $60.64 | +5.5% | Jun 23, 2026 |
| UBS | Graham Doyle | $69 | $64.26 | -9.0% | May 21, 2026 |
| Evercore ISI | Analyst unavailable | $80 | $59.81 | +5.5% | Apr 30, 2026 |
| Oppenheimer | Suraj Kalia | $85 | $60.04 | +12.1% | Apr 30, 2026 |
| Barclays | Matt Miksic | $78 | $59.48 | +2.9% | Apr 30, 2026 |
| Goldman Sachs | David Roman | $65 | $59.48 | -14.3% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $80 | $60.06 | +5.5% | Apr 29, 2026 |
| Piper Sandler | Analyst unavailable | $88 | $73.2 | +16.1% | Apr 17, 2026 |
| Mizuho Securities | Analyst unavailable | $90 | $72.69 | +18.7% | Apr 13, 2026 |
| Barclays | Analyst unavailable | $87 | $82.31 | +14.7% | Feb 6, 2026 |
| Stifel Nicolaus | Rick Wise | $98 | $82.63 | +29.3% | Feb 4, 2026 |
| Morgan Stanley | Analyst unavailable | $85 | $82.63 | +12.1% | Feb 4, 2026 |
| BTIG | Ryan Zimmerman | $91 | $83.7 | +20.0% | Feb 4, 2026 |
| Piper Sandler | Analyst unavailable | $94 | $78.78 | +24.0% | Jan 30, 2026 |
| UBS | Analyst unavailable | $77 | $85.3 | +1.6% | Jan 15, 2026 |
| Goldman Sachs | Analyst unavailable | $98 | $88.16 | +29.3% | Jan 9, 2026 |
| Stifel Nicolaus | Analyst unavailable | $95 | $86.73 | +25.3% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $95 | $84.2 | +25.3% | Jan 5, 2026 |
| Jefferies | Analyst unavailable | $105 | $85.54 | +38.5% | Dec 11, 2025 |
| Stifel Nicolaus | Rick Wise | $90 | $76.29 | +18.7% | Nov 21, 2025 |
| Wells Fargo | Larry Biegelsen | $87 | $77.38 | +14.7% | Oct 30, 2025 |
| BTIG | Analyst unavailable | $87 | $77.38 | +14.7% | Oct 29, 2025 |
| BTIG | Ryan Zimmerman | $89 | $71.01 | +17.4% | Oct 13, 2025 |
| Barclays | Analyst unavailable | $86 | $71.01 | +13.4% | Oct 13, 2025 |
| Morgan Stanley | Analyst unavailable | $74 | $74 | -2.4% | Sep 18, 2025 |
| UBS | Graham Doyle | $73 | $69.37 | -3.7% | May 5, 2025 |
| BTIG | Ryan Zimmerman | $95 | $64.39 | +25.3% | Apr 14, 2025 |
| Piper Sandler | Jason Bednar | $97 | $82.08 | +27.9% | Nov 15, 2024 |
| UBS | Graham Doyle | $74 | $93.01 | -2.4% | Sep 26, 2024 |
| Bank of America Securities | Craig Bijou | $97 | $90.62 | +27.9% | Sep 20, 2024 |
| BTIG | Ryan Zimmerman | $100 | $86.79 | +31.9% | Sep 18, 2024 |
| Goldman Sachs | David Roman | $87 | $78.45 | +14.7% | May 30, 2024 |
| Piper Sandler | Jason Bednar | $92 | $81.5 | +21.3% | May 21, 2024 |
| Mizuho Securities | Anthony Petrone | $105 | $77.74 | +38.5% | May 1, 2024 |
| Evercore ISI | Vijay Kumar | $96 | $76.24 | +26.6% | Apr 30, 2024 |
| Mizuho Securities | Anthony Petrone | $110 | $85.39 | +45.1% | Apr 11, 2024 |
| Argus Research | David Toung | $110 | $90.91 | +45.1% | Apr 1, 2024 |
| UBS | Graham Doyle | $88 | $83.17 | +16.1% | Feb 12, 2024 |
| Morgan Stanley | Patrick Wood | $76 | $77.17 | +0.2% | Jun 27, 2023 |
| Oppenheimer | Suraj Kalia | $97 | $77 | +27.9% | May 16, 2023 |
Track every rating change on GEHC the moment it posts. Free to start.
Start freeGet the GEHC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.